Acute Lymphoblastic Leukemia
📧 Sign up to get email alerts when something new happens for Acute Lymphoblastic Leukemia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS guidance · 2026-03-02Clinical Trial Update: Recommendations for the Treatment of Children With Acute Lymphoblastic Leukemia in the GFAOP
The document provides recommendations for treating children with acute lymphoblastic leukemia within the GFAOP network. It outlines updated …
-
EMA guidance · 2013-11-22European Medicines Agency recommends changes in use of leukaemia medicine Iclusig (ponatinib) in order to minimise risk of blood clots
EMA recommends changes in how ponatinib (Iclusig) is used to reduce the risk of blood clots in leukemia treatment.